Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer

Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype

Katrina Bauer, Monica Brown, Rosemary D. Cress et al. · Cancer · 2007 · 2.1K citations

Medicine, Oncology, Breast Oncology +11

Role of CD47 as a Marker of Self on Red Blood Cells

Per‐Arne Oldenborg, Alex Zheleznyak, Yifu Fang et al. · Science · 2000 · 1.9K citations

Life Sciences, Cell Biology, Immunology +17

Targeted drug delivery to tumors: Myths, reality and possibility

You Han Bae, Kinam Park · Journal of Controlled Release · 2011 · 1.9K citations · Full text

Pharmacy, Oncology, Pharmacology +12

Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting

Oscar P. B. Wiklander, Joel Z. Nordin, Aisling J. O’Loughlin et al. · Journal of Extracellular Vesicles · 2015 · 1.7K citations · Full text

Pharmacy, Cell Biology, Pharmaceutics +15

Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications

Jinjun Shi, Alexander R. Votruba, Omid C. Farokhzad et al. · Nano Letters · 2010 · 1.6K citations · Full text

Engineering, Bioengineering, Biomedical Engineering +13